Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

805 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From chemistry to genomics: A concise history of the porphyrias.
Badminton MN, Anderson KE, Deybach JC, Harper P, Sandberg S, Elder GH. Badminton MN, et al. Among authors: anderson ke. Liver Int. 2024 May 20. doi: 10.1111/liv.15960. Online ahead of print. Liver Int. 2024. PMID: 38767598 Review.
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Frank S, Anderson KE, Fernandez HH, Hauser RA, Claassen DO, Stamler D, Factor SA, Jimenez-Shahed J, Barkay H, Wilhelm A, Alexander JK, Chaijale N, Barash S, Savola JM, Gordon MF, Chen M. Frank S, et al. Among authors: anderson ke. Neurol Ther. 2024 Apr 1. doi: 10.1007/s40120-024-00600-1. Online ahead of print. Neurol Ther. 2024. PMID: 38557959
Global patterns of allochthony in stream-riparian meta-ecosystems.
Allen DC, Larson J, Murphy CA, Garcia EA, Anderson KE, Busch MH, Argerich A, Belskis AM, Higgins KT, Penaluna BE, Saenz V, Jones J, Whiles MR. Allen DC, et al. Among authors: anderson ke. Ecol Lett. 2024 Mar;27(3):e14401. doi: 10.1111/ele.14401. Ecol Lett. 2024. PMID: 38468439 Review.
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study.
Reilmann R, Anderson KE, Feigin A, Tabrizi SJ, Leavitt BR, Stout JC, Piccini P, Schubert R, Loupe P, Wickenberg A, Borowsky B, Rynkowski G, Volkinshtein R, Li T, Savola JM, Hayden M, Gordon MF; LEGATO-HD Study Group. Reilmann R, et al. Among authors: anderson ke. Lancet Neurol. 2024 Mar;23(3):243-255. doi: 10.1016/S1474-4422(23)00454-4. Epub 2024 Jan 24. Lancet Neurol. 2024. PMID: 38280392 Clinical Trial.
805 results